During the past decade, Ospedale San Salvatore conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale San Salvatore" #1 sponsor was "University Hospital of Ferrara" with 2 trials, followed by "Aboca Spa Societa' Agricola" with 1 trials sponsored, "Catholic University of the Sacred Heart" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored and "Dompé Farmaceutici S.p.A" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale San Salvatore" #1 collaborator was "AUSL Romagna Rimini" with 1 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Azienda Ospedaliera San Gerardo di Monza" with 1 trials as a collaborator, "BMR Genomics" with 1 trials as a collaborator and "Centre for Neonatal Research and Education, Crawley, West Australia" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale San Salvatore" are "Psoriasis" (2 trials), "Advanced Cutaneous Squamous Cell Carcinoma" (1 trials), "Asphyxia Perinatal" (1 trials), "Atrial Fibrillation" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Ospedale San Salvatore" in a lesser frequency.

Most popular intervention types in "Ospedale San Salvatore" are "Drug" (8 trials), "Other" (4 trials), "Device" (3 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Alectinib" (1 trials), "Alpelisib" (1 trials), "Atezolizumab" (1 trials), "Brigatinib" (1 trials) and "Cobimetinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale San Salvatore" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale San Salvatore". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Ospedale San Salvatore, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale San Salvatore, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".